3D Tissue Models: Oncology will host translational, preclinical, and efficacy experts from leading pharma and biotech companies worldwide to realize the practical applications of these models. Attending delegates are actively seeking solutions utilizing 3D constructs that can be applied to the drug discovery setting including:
We are inviting established vendors in this space to educate our audience of industry leaders about what can be achieved and to provide the platforms and technology that can accelerate validation of target molecules, expedite time to the clinic, and reduce attrition rates and the cost to bring drugs to market.
This unparalleled opportunity to showcase your capabilities and establish your credibility in this nascent market.
If you have a product or service that will benefit this audience, please contact us at email@example.com to discuss how we can help you reach this audience.
Who Should Partner:
Model Developers & Equipment Providers
This is your opportunity to ensure that you’re front of mind when biopharma organizations outsource translational and preclinical services to aid in go/no-go decisions. We’ve worked with Lonza and Organovo to help them develop strategic relationships across the field through effective positioning alongside the leading pharmaceutical organizations.
Contract Research Organizations
Engage directly with decision makers at biopharma and CROs to showcase your 3D models, imaging and assay